2:18cv14091 • September 20, 2018
Class Period Start
September 23, 2013
Class Period End
December 7, 2018
PSLRA Deadline
November 19, 2018
Case Allegations
10b5
Statutes of Repose
Sep 23, 2016
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
November 16, 2020
Settlement Fund
$1,265,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased or otherwise acquired the publicly-traded securities of Cocrystal Pharma, Inc. (“Cocrystal”) and/or BioZone Pharmaceuticals, Inc. (“BioZone”) during the period between September 23, 2013 and September 7, 2018, both dates inclusive
Claim Administrator
Strategic Claims Services
Cocrystal Pharma, Inc. Securities Litigation
c/o Strategic Claims Services
600 N. Jackson St., Ste. 205
P.O. Box 230
Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
https://www.strategicclaims.net/cocrystal/Hearing Date
December 16, 2020
Opt-out Deadline
November 25, 2020
Settlement Note
Download hereProof Of Claim
Download here
Sep 1, 2021
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Dec 16, 2020
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Aug 18, 2020
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Aug 18, 2020
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
May 26, 2020
May 26, 2020
Oct 1, 2019
Aug 22, 2019
Jun 25, 2019
A new complaint has been filed on behalf of certain investors in Cocrystal Pharma, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Apr 26, 2019
Apr 9, 2019
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Sep 20, 2018
A securities fraud class action complaint has been filed on behalf of certain investors in Cocrystal Pharma, Inc..
TOP
